Michael Lee, MD
Surgery · Denton, TXNPI 1598969362
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (44.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Intuitive Surgical at 57.4% of the total. Reporting peaked in 2019 at $9,657 and has fallen 97.9% since, to $207 in 2025.
Across 85 payments — averaging $185.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- Medical Device Business Services, Inc.$4K
- W. L. Gore & Associates, Inc.$2K
- Johnson & Johnson$571
- TELA Bio, Inc.$296
- Revance Therapeutics, Inc.$145
- plus $487 from 11 others
What the payments were for
- Consulting fees$3,51022%
- Travel & lodging$1,74311%
- Food & beverage$3,44822%
- Education$7,02345%
- Gifts$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 24 | $9,038 |
| Medical Device Business Services, Inc. | 5 | $3,662 |
| W. L. Gore & Associates, Inc. | 11 | $1,533 |
| Johnson & Johnson(2 entities) | 28 | $571 |
| TELA Bio, Inc. | 2 | $296 |
| Revance Therapeutics, Inc. | 1 | $145 |
| AbbVie | 1 | $143 |
| Acell, Inc. | 1 | $120 |
| Novo Nordisk | 3 | $57 |
| Phathom Pharmaceuticals, Inc. | 2 | $50 |
| Conmed Corporation | 1 | $24 |
| Endo Pharmaceuticals Inc. | 1 | $21 |
| Vivus LLC | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Mallinckrodt Enterprises LLC | 1 | $11 |
| Levita Magnetics International Corp | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,732 in reported general payments places this provider in the 80th percentile of 1,830 surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 19 | $263 |
| Ondansetron OdtOndansetron | 16 | $158 |
| Tramadol Hcl | 18 | $73 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $71 |
Paid to pharmacies, not to this prescriber.
Other surgery in Denton
- Folahan AyoolaDenton$570K
- Franklin CharneyDenton$567K
- Michael HarkinsTomball$2.7M
- Douglas StoddardAustin$1.4M
- Steven FassAustin$989K
- Vineet ChoudhryAustin$851K
- Andy HawthorneRound Rock$843K
- Nancy MarquezAustin$700K
- Sachin KukrejaDallas$640K
- Alejandro EsquivelAustin$631K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.